Uncategorized
March 23 in Fort Lauderdale: Two Experts to Speak about Taboo Health Subjects for Gay Men
FOR IMMEDIATE RELEASE CONTACT: STEVE STAGON, 954-815-2550 Two Experts to Speak about Taboo Health Subjects for Gay Men March 15, 2011- Fort Lauderdale, FL. Two lectures sponsored by the PALS Project and “Life Goes On” Elton John Foundation will be provided by top experts who will speak about anal and erectile health, two topics that …
How to Improve Finances Despite HIV
FREE WORSKSHOP Program for Wellness Restoration, the Houston Buyers Club and LIVE Consortium present What to Do Now that You are Living Longer? How to Improve Finances Despite HIV A seminar with author & financial advisor Per Larson *Limited seating* March 22, 6:30 pm- United Way-50 Waugh Drive-Houston, TX 77007 Register here : https://hivpersonalfinances.eventbrite.com/ Among the …
Dolutegravir, Trii and new abacavir data- How it all ties together
By Nelson Vergel Powerusa.org Dr Joe Eron presented new dosing and efficacy phase 2b data on the new GSK integrase inhibitor dolutegravir (DTG, S/GSK1349572) using 50 mg twice a day in patients whose HIV virus has developed resistance to raltegravir (Isentress). Prior data presented in Vienna from a cohort (cohort 1) of patients who took …
Dolutegravir, Trii and new abacavir data- How it all ties together Read More »
The Long-Term Survivor Dilemma
From https://www.thebody.com/content/art60472.html?ts=pf By Nelson Vergel February 14, 2011 “Nelson, what am I going to do?” This sentence is part of a conversation that I seem to be having everywhere I go with my seminars — one that manifests from a communal concern that many of us are sharing as we age as HIV long-term survivors. …
Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?
Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? By Nelson Vergel March 2, 2011 Jay Lalezari, M.D., from the University of California-San Francisco presented first-of-its-kind study data on the use of zinc finger nucleases (ZFNs) to artificially disrupt the CCR5 receptor on the surface of CD4 cells, which HIV uses to infect its …
Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? Read More »
The FDA says abacavir (Ziagen) does not cause cardiovascular problems, opening the door for GSK to combine it with their new integrase inhibitor for naive patients
This will make it possible for GSK-ViiV to market their new Trii formulation of the new integrase inhibitor GSK572 (generic name: dolutegravir) plus Epzicom (abacavir plus epivir) as a once a day pill for naive patients It contradicts all the previous studies that said that abacavir (Ziagen) causes increased cardiovascular risks. https://www.aidsmap.com/page/1682771/ GSK is currently …
HIV Gene Therapy Data Update
HIV Gene Therapy Data Update HIV Gene Therapy Data Reported This Month Sangamo Says Experimental Therapy Kept HIV Level Low By Rob Waters – January 19, 2010 16:05 EST Jan. 19 (Bloomberg) — Sangamo BioSciences Inc., a company developing gene-based therapies for AIDS and other conditions, said an experimental treatment kept down levels of HIV, …
HIV Wellness powerpoint presentation by Nelson Vergel
HIV Wellness (click each slide on the right side to proceed) More PowerPoint presentations from Nelson Vergel
Hitting the gym with fitness stud Nelson Vergel
From: Mark S. King <mark@marksking.com> Sent: Thu, Feb 3, 2011 4:31 am Subject: Hitting the gym with fitness stud Nelson Vergel HIV advocate and fitness expert Nelson Vergel agrees to help me with a monumental task: losing weight. In the second part of a three-part video series, we hit the gym for lessons on aerobic …
Interview with author Nelson Vergel about his new book
Full Nelson [ 0 ]February 1, 2011 | Steven Foster 3Share Back by popular demand: author Nelson Vergel wrote Testosterone: A Man’s Guide in part to respond to men’s queries about their diminishing sex drives. Speaker, survivor, and author Nelson Vergel gives OutSmart the no-longer-skinny on ‘Testosterone: A Man’s Guide,’ his first book in over a decade by …
Interview with author Nelson Vergel about his new book Read More »